强直性脊柱炎单细胞转录组与表面蛋白表达分析鉴定OX40阳性及糖皮质激素诱导肿瘤坏死因子受体阳性致病性Th17细胞
研究纳入活动性强直性脊柱炎40例、稳定期强直性脊柱炎20例、活动性类风湿关节炎40例及健康对照20例,采用流式细胞术与单细胞转录组结合表面表位测序分析血液和滑液细胞,发现致病性Th17细胞为多能IL-17A和IFNγ产生的记忆CD4+ T细胞,其TNFRSF4(OX40)与TNFRSF18(GITR)共表达增高,在小鼠模型中抑制OX40与GITR配体受体相互作用可抑制临床关节炎并减少致病性Th17细胞。
要点
- 致病性Th17细胞为多能IL-17A和IFNγ产生的记忆CD4+ T细胞,在强直性脊柱炎炎症部位有临床支持证据。
- 转录组和流式分析显示致病性Th17细胞中TNFRSF4(OX40)与TNFRSF18(GITR)共表达增高。
- 在curdlan注射SKG小鼠模型中抑制OX40和GITR配体受体相互作用可有效抑制临床关节炎并减少致病性Th17细胞。
核心结论
- 研究结果有助于理解强直性脊柱炎患者的致病性Th17细胞,并提示潜在治疗靶点。
研究设计与样本
- 研究纳入活动性强直性脊柱炎40例、稳定期强直性脊柱炎20例、活动性类风湿关节炎40例和健康对照20例。
- 外周血单个核细胞和滑液单个核细胞经T细胞受体刺激后,用流式细胞术评估表面表型和细胞内染色。
- 对6例活动性强直性脊柱炎患者进行单细胞转录组研究,并结合转录组与表位的细胞索引测序。
- 在curdlan注射SKG小鼠模型中使用抗GITR配体和/或抗OX40配体,评估靶向Th17细胞表面OX40和GITR的结果。
主要发现
- 鉴定出致病性Th17细胞为多能IL-17A和IFNγ产生的记忆CD4+ T细胞,并有临床支持证据表明其在强直性脊柱炎炎症部位发挥致病作用。
- 转录组和流式细胞术分析显示,致病性Th17细胞中TNFRSF4(OX40)和TNFRSF18(GITR)的共表达增高。
- 在curdlan注射SKG小鼠模型中,通过OX40和GITR在体内抑制配体受体相互作用,有效抑制了临床关节炎并减少了致病性Th17细胞。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To demonstrate the immune landscape of blood and synovial cells in the setting of ankylosing spondylitis (AS) through the analysis of both single-cell transcriptome and surface protein expression, and to unveil the molecular characteristics of pathogenic Th17 cells. METHODS: This study included 40 individuals with active AS, 20 individuals with stable AS, 40 patients with active rheumatoid arthritis, and 20 healthy controls. Surface phenotype and intracellular staining were assessed using flow cytometry after peripheral blood mononuclear cells and synovial fluid mononuclear cells were stimulated with T cell receptor. Single-cell transcriptomes of 6 patients with active AS were studied along with cellular indexing of transcriptomes and epitopes by sequencing. We also assessed the outcome of targeting OX40 and glucocorticoid-induced tumor necrosis factor receptor (GITR) on the surface of Th17 cells in a mouse model of curdlan-injected SKG mice in which anti-GITR ligand and/or anti-OX40 ligand were used. RESULTS: We identified pathogenic Th17 cells as polyfunctional interleukin-17A (IL-17A)- and interferon-γ (IFNγ)-producing memory CD4+ T cells, with clinically supportive evidence for their pathogenic roles at sites of inflammation in AS. Transcriptome and flow cytometric analyses revealed that the coexpression of TNFRSF4 (OX40) and TNFRSF18 (GITR) is increased in pathogenic Th17 cells. Suppression of ligand receptor interactions in vivo through OX40 and GITR effectively suppressed clinical arthritis and decreased pathogenic Th17 cells in the curdlan-injected SKG mouse model. CONCLUSION: Our results have implications for the understanding of pathogenic Th17 cells in AS patients and suggest potential therapeutic targets.
引用
- Yi K, Jo S, Song W, et al. Analysis of Single-Cell Transcriptome and Surface Protein Expression in Ankylosing Spondylitis Identifies OX40-Positive and Glucocorticoid-Induced Tumor Necrosis Factor Receptor-Positive Pathogenic Th17 Cells. Arthritis Rheumatol. 2023. PMID: 36787119. doi:10.1002/art.42476
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。